Qingfeng Ni
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- MicroRNA in disease regulation 12
- Cancer-related molecular mechanisms research 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Co-authors
- Jiawei Yu (5 shared papers)Wei Hsian Yin (2 shared papers)Lianbao Kong (4 shared papers)Yan Zhang (2 shared papers)Peisheng Chen (2 shared papers)Wenzhou Ding (3 shared papers)Xiaolong Li (3 shared papers)Jianwei Zhu (3 shared papers)
In The Last Decade
Qingfeng Ni
31 papers receiving 624 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 180
- Gastroenterology 28
- Oncology 89
- Immunology and Allergy 19
- Hepatology 22
Countries citing papers authored by Qingfeng Ni
This map shows the geographic impact of Qingfeng Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfeng Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfeng Ni more than expected).
Fields of papers citing papers by Qingfeng Ni
This network shows the impact of papers produced by Qingfeng Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfeng Ni. The network helps show where Qingfeng Ni may publish in the future.
Co-authors
The 25 scholars most cited alongside Qingfeng Ni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 86 | |
| 2 | 2018 | 57 | |
| 3 | 2019 | 57 | |
| 4 | 2017 | 53 | |
| 5 | 2019 | 32 | |
| 6 | 2016 | 29 | |
| 7 | 2015 | 28 | |
| 8 | 2019 | 28 | |
| 9 | 2023 | 28 | |
| 10 | 2020 | 27 | |
| 11 | 2019 | 26 | |
| 12 | 2021 | 24 | |
| 13 | 2014 | 20 | |
| 14 | The expression of AEG-1 and Cyclin D1 in human bladder urothelial carcinoma and their clinicopathological significance. | 2015 | 16 |
| 15 | 2013 | 15 | |
| 16 | 2014 | 15 | |
| 17 | 2013 | 13 | |
| 18 | 2022 | 12 | |
| 19 | 2015 | 11 | |
| 20 | 2021 | 8 |
About Qingfeng Ni
Qingfeng Ni is a scholar working on Cancer Research, Hepatology, Pulmonary and Respiratory Medicine, Surgery and Molecular Biology, having authored 33 papers that have together received 638 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (12 papers), Gastric Cancer Management and Outcomes (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Mechanisms of cancer metastasis (3 papers), Proteoglycans and glycosaminoglycans research (2 papers), Cancer-related molecular mechanisms research (2 papers), Organ Transplantation Techniques and Outcomes (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Cancer Research (180 citations), Gastroenterology (28 citations), Oncology (89 citations), Immunology and Allergy (19 citations) and Hepatology (22 citations). Qingfeng Ni has collaborated with scholars based in China, Norway and Denmark. Frequent co-authors include Jiawei Yu, Wei Hsian Yin, Lianbao Kong, Yan Zhang, Peisheng Chen, Wenzhou Ding, Xiaolong Li, Jianwei Zhu, Xiangcheng Li and Liyong Pu. Their work appears in journals such as Acta Biochimica et Biophysica Sinica, International Journal of Oncology, Aging, Journal of Cellular Biochemistry and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.